SXTP expands ARAKODA label for babesiosis
A clinical development program targets expanding ARAKODA’s label from malaria into babesiosis, with an interim analysis in October and a potential early-2028 launch.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.